CHICAGO, March 13, 2023 /PRNewswire/ -- Lung cancer is the leading cause of cancer deaths in the United States, but advancements in research and treatment are leading to improved survival rates. The ...
Joshua Sabari, MD, assistant professor of medicine, Medical Oncology, Perlmutter Cancer Center at NYU Langone Health, New York, New York, discusses topics involving next generation sequencing (NGS) to ...
HOUSTON ― A Phase II clinical trial of poziotinib for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 mutations, led by researchers at The University of Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback